xAI Limits Staff Contact With Cursor Ahead of Deal

Per Bloomberg, xAI's general counsel, James Burnham, sent guidelines last week telling employees to moderate contact with Cursor staff and to limit interactions to what is necessary to implement the companies' existing technical partnership, according to people familiar with the matter. PYMNTS reports that the partnership was announced on April 21 in separate posts by the companies.

PYMNTS quotes a Cursor post saying, "We've wanted to push our training efforts much further, but we've been bottlenecked by compute," and that the team will "leverage xAI's Colossus infrastructure to dramatically scale up the intelligence of our models," per the report. Both outlets frame the current communications restrictions as tied to the firms' announced technical collaboration rather than joint product development prior to regulatory clearance.

Companies pursuing close technical partnerships while talks about acquisition or investment are public frequently use targeted access controls and legal guidance to separate collaboration workstreams from sensitive merger discussions. Industry observers often note these measures aim to reduce antitrust exposure by limiting joint decision-making and preventing premature integration of assets or personnel.

For practitioners, the episode is notable because it illustrates how high-profile AI infrastructure collaborations, here involving xAI and Cursor and referencing Colossus compute, can trigger standard corporate compliance steps when acquisition possibilities enter the public sphere. Reporting does not indicate a completed transaction; PYMNTS characterizes the guidance as precautionary and grounded in standard legal practice.

Monitor follow-on reporting from Bloomberg and official statements from the companies for any formal filing, definitive acquisition terms, or public regulatory notices. Observers will also watch whether the technical partnership yields measurable model-training scaleups once compute access is implemented and whether additional regulatory scrutiny appears in subsequent coverage.